Randomized Feasibility Study of S-1 for Adjuvant Chemotherapy in Completely-Resected Stage IA Non-Small-Cell Lung Cancer (SLCG 0701)

被引：0
|
作者：
Okumura, Norihito [1 ]
Soh, Junichi [2 ]
Nakata, Masao [3 ]
Nakamura, Hiroshige [4 ]
Fukuda, Minoru [5 ]
Kataoka, Masafumi [6 ]
Kajiwara, Shinsuke [7 ]
Sano, Yoshifumi [8 ]
Aoe, Motoi [9 ]
Kataoka, Kazuhiko [10 ]
Hotta, Katsuyuki [2 ]
Matsuo, Keitaro [11 ]
Toyooka, Shinichi [2 ]
Date, Hiroshi [12 ]
机构：
[1] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan
[3] Kawasaki Med Sch, Kurashiki, Okayama, Japan
[4] Tottori Univ, Fac Med, Yonago, Tottori 683, Japan
[5] Japanese Red Cross Nagasaki Genbaku Hosp, Nagasaki, Japan
[6] Okayama Saiseikai Gen Hosp, Okayama, Japan
[7] Uwajima City Hosp, Uwajima, Japan
[8] Ehime Univ Hosp, Touon, Japan
[9] Kagawa Prefectural Cent Hosp, Takamatsu, Kagawa, Japan
[10] Iwakuni Clin Ctr, Iwakuni, Japan
[11] Kyushu Univ, Fac Med Sci, Fukuoka 812, Japan
[12] Kyoto Univ, Grad Sch Med, Kyoto, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
adjuvant chemotherapy; Non-small-cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.02-032
引用
收藏
页码：S440 / S441
页数：2
相关论文
共 50 条
  • [41] Feasibility study for biweekly administration of cisplatin plus gemcitabine as adjuvant-chemotherapy for completely resected non-small cell lung cancer
    Masafumi Yamaguchi
    Sadanori Takeo
    Ryuichi Suemitsu
    Hironori Matsuzawa
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 107 - 112
  • [42] Feasibility study for biweekly administration of cisplatin plus gemcitabine as adjuvant-chemotherapy for completely resected non-small cell lung cancer
    Yamaguchi, Masafumi
    Takeo, Sadanori
    Suemitsu, Ryuichi
    Matsuzawa, Hironori
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (01) : 107 - 112
  • [43] Adjuvant chemotherapy or immunotherapy for completely resected stage IB non-small cell lung cancer: still a grey zone?
    Lee, Kuan-Yu
    Hsu, Chen-Xiong
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (03) : 647 - 648
  • [44] Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research
    Maria Bonomi
    Sara Pilotto
    Michele Milella
    Francesco Massari
    Sara Cingarlini
    Matteo Brunelli
    Marco Chilosi
    Giampaolo Tortora
    Emilio Bria
    Journal of Experimental & Clinical Cancer Research, 30
  • [45] Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research
    Bonomi, Maria
    Pilotto, Sara
    Milella, Michele
    Massari, Francesco
    Cingarlini, Sara
    Brunelli, Matteo
    Chilosi, Marco
    Tortora, Giampaolo
    Bria, Emilio
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2011, 30
  • [46] Split-dose Cisplatin and Vinorelbine as Adjuvant Chemotherapy for Completely Resected Non-small Cell Lung Cancer
    Hirai, Fumihiko
    Seto, Takashi
    Shimokawa, Mototsugu
    Inamasu, Eiko
    Toyozawa, Ryo
    Toyokawa, Gouji
    Yoshida, Tsukihisa
    Shiraishi, Yoshimasa
    Takenaka, Tomoyoshi
    Yamaguchi, Masafumi
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    ANTICANCER RESEARCH, 2014, 34 (02) : 927 - 931
  • [47] Adjuvant chemotherapy following radical surgery for non-small-cell lung cancer: a randomized study on 70 patients
    Xu, GC
    Rong, TH
    Lin, P
    CHINESE MEDICAL JOURNAL, 2000, 113 (07) : 617 - 620
  • [48] Can adjuvant chemotherapy improve survival in patients with early-stage, resected non-small-cell lung cancer?
    Azzoli, CG
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (11): : 552 - 553
  • [49] Acceptability and feasibility of S-1 plus cisplatin adjuvant chemotherapy for completely resected non-small cell lung cancer: an open-label, single arm, multicenter, phase 2 trial
    Uematsu, Shugo
    Sano, Atsushi
    Isobe, Kazutoshi
    Usui, Kazuhiro
    Matsumoto, Jun
    Kiribayashi, Takaharu
    Obara, Kiyohaya
    Kitami, Akihiko
    Murakami, Yoshitaka
    Iyoda, Akira
    JOURNAL OF THORACIC DISEASE, 2021, 13 (04) : 2224 - 2232
  • [50] Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: What makes it worthwhile?
    Blinman, Prunella
    Hughes, Brett
    Crombie, Catherine
    Christmas, Tim
    Hudson, Malcolm
    Veillard, Anne-Sophie
    Muljadi, Nick
    Millward, Michael
    Wright, Gavin
    Flynn, Peter
    Windsor, Morgan
    Stockler, Martin
    McLachlan, Sue-Anne
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (12) : 1529 - 1537
12345